Literature DB >> 34623103

Neurologic Complications of Lyme Disease.

Karen L Roos.   

Abstract

PURPOSE OF REVIEW: This article reviews the symptomatology, diagnosis, and treatment of neuroborreliosis. RECENT
FINDINGS: The most recent guidelines for the diagnosis and treatment of Lyme disease were published in 2020 by the Infectious Diseases Society of America, the American Academy of Neurology, and the American College of Rheumatology.
SUMMARY: The most common neurologic complications of Lyme disease are cranial neuritis (most often a unilateral or bilateral facial nerve palsy), meningitis, and radiculoneuritis/mononeuropathy multiplex. Testing for Lyme disease begins with an enzyme-linked immunosorbent assay (ELISA). If the ELISA is positive or borderline, Western blots should be performed for both IgM and IgG antibodies. As a general rule, in infectious diseases, an IgM antibody response is followed by an IgG antibody response. A central nervous system infection has either a CSF pleocytosis or pathogen-specific intrathecal antibody production. Lyme meningitis, cranial neuropathy, radiculoneuropathy, or other peripheral nervous system manifestations are treated with oral doxycycline or IV ceftriaxone, cefotaxime, or penicillin G. No additional antibiotic therapy is indicated for patients with posttreatment Lyme disease syndrome or patients with concern for chronic Lyme disease with no evidence of previous or current Lyme infection.
Copyright © 2021 American Academy of Neurology.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34623103     DOI: 10.1212/CON.0000000000001015

Source DB:  PubMed          Journal:  Continuum (Minneap Minn)        ISSN: 1080-2371


  2 in total

1.  Atypical Case of Lyme Neuroborreliosis With Hyponatremia.

Authors:  Dhara Rana; Mujtaba Chohan; Nagwa Hafez
Journal:  Cureus       Date:  2022-04-23

2.  Rare case of acute transverse myelitis associated with Lyme neuroborreliosis.

Authors:  Mujtaba Chohan; Dhara Rana; Nagwa Hafez
Journal:  IDCases       Date:  2022-01-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.